CBM2

Prof. Soper gives presentation at TRI-CON Conference

Center Director, Professor Steve Soper will give a presentation at the TRI-CON Conference at the Moscone Center in San Francisco, CA, on interrogating DNA damage in CTCs to monitor response to therapy. The technology uses nanofluidic devices emanating from CBM2 to stretch DNA and optically read the chemotherapy-induced DNA damage sites.

March 22, 2017